Bio-Thera Solutions, Ltd. (SHA:688177)
16.16
-0.56 (-3.35%)
At close: Nov 16, 2026
Bio-Thera Solutions Revenue
Bio-Thera Solutions had revenue of 279.08M CNY in the quarter ending September 30, 2026, with 15.47% growth. This brings the company's total for the last twelve months to 1.05B, up 24.13% year-over-year. In the year 2025, Bio-Thera Solutions had annual revenue of 935.22M with 25.84% growth. That makes Bio-Thera Solutions the 19,255th largest company in the world by revenue and 3,524th in China.
Revenue (ttm)
1.05B
Revenue Growth
+24.13%
P/S Ratio
6.38
Revenue / Employee
735.81K
Employees
1,471
Market Cap
6.69B
Revenue by Geography
- China 878.06M 93.9%
- Overseas 57.16M 6.1%
Fiscal year ended Dec 31, 2025 See the full Bio-Thera Solutions breakdown
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 935.22M | 192.05M | 25.84% |
| Dec 31, 2024 | 743.17M | 38.37M | 5.44% |
| Dec 31, 2023 | 704.79M | 249.66M | 54.86% |
| Dec 31, 2022 | 455.13M | -381.45M | -45.60% |
| Dec 31, 2021 | 836.58M | 653.72M | 357.49% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. It does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Star Lake Bioscience Co., Inc.Zhaoqing Guangdong | 16.13B |
| Novogene | 2.30B |
| Jiangxi Fushine Pharmaceutical | 1.97B |
| Aurisco Pharmaceutical | 1.67B |
| China Resources Boya Bio-pharmaceutical Group Co.,Ltd | 1.43B |
| Vcanbio Cell & Gene Engineering Corp., | 1.38B |
| Chengdu Easton Biopharmaceuticals | 1.30B |
| Daan Gene | 776.43M |